1. Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Bonifacio E, Mathieu C, Nepom GT, Ziegler AG, Anhalt H, Haller MJ, Harrison LC, Hebrok M, Kushner JA, Norris JM, Peakman M, Powers AC, Todd JA, Atkinson MA (2017) Diabetologia 60(1): 35-38
    › Primary publication · 27785529 (PubMed) · PMC5516264 (PubMed Central)
  2. Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Campbell-Thompson ML, Atkinson MA, Butler AE, Giepmans BN, von Herrath MG, Hyöty H, Kay TW, Morgan NG, Powers AC, Pugliese A, Richardson SJ, In't Veld PA (2017) Diabetologia 60(4): 753-755
    › Primary publication · 28070616 (PubMed) · PMC5415083 (PubMed Central)
  3. Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Babon JA, DeNicola ME, Blodgett DM, Crèvecoeur I, Buttrick TS, Maehr R, Bottino R, Naji A, Kaddis J, Elyaman W, James EA, Haliyur R, Brissova M, Overbergh L, Mathieu C, Delong T, Haskins K, Pugliese A, Campbell-Thompson M, Mathews C, Atkinson MA, Powers AC, Harlan DM, Kent SC (2017) Nat Med 23(2): 264
    › Primary publication · 28170374 (PubMed)
  4. Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes. Virostko J, Hilmes M, Eitel K, Moore DJ, Powers AC (2016) PLoS One 11(7): e0158825
    › Primary publication · 27391588 (PubMed) · PMC4938534 (PubMed Central)
  5. Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease. Ziegler AG, Bonifacio E, Powers AC, Todd JA, Harrison LC, Atkinson MA (2016) Diabetes 65(11): 3233-3239
    › Primary publication · 27959859 (PubMed) · PMC5860440 (PubMed Central)
  6. The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice. Ceddia RP, Lee D, Maulis MF, Carboneau BA, Threadgill DW, Poffenberger G, Milne G, Boyd KL, Powers AC, McGuinness OP, Gannon M, Breyer RM (2016) Endocrinology 157(1): 220-32
    › Primary publication · 26485614 (PubMed) · PMC4701878 (PubMed Central)
  7. The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cells. Conrad E, Dai C, Spaeth J, Guo M, Cyphert HA, Scoville D, Carroll J, Yu WM, Goodrich LV, Harlan DM, Grove KL, Roberts CT, Powers AC, Gu G, Stein R (2016) Am J Physiol Endocrinol Metab 310(1): E91-E102
    › Primary publication · 26554594 (PubMed) · PMC4675799 (PubMed Central)
  8. Stress-impaired transcription factor expression and insulin secretion in transplanted human islets. Dai C, Kayton NS, Shostak A, Poffenberger G, Cyphert HA, Aramandla R, Thompson C, Papagiannis IG, Emfinger C, Shiota M, Stafford JM, Greiner DL, Herrera PL, Shultz LD, Stein R, Powers AC (2016) J Clin Invest 126(5): 1857-70
    › Primary publication · 27064285 (PubMed) · PMC4855919 (PubMed Central)
  9. Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas. Wang YJ, Golson ML, Schug J, Traum D, Liu C, Vivek K, Dorrell C, Naji A, Powers AC, Chang KM, Grompe M, Kaestner KH (2016) Cell Metab 24(4): 616-626
    › Primary publication · 27732837 (PubMed) · PMC5123805 (PubMed Central)
  10. Replicative capacity of β-cells and type 1 diabetes. Saunders D, Powers AC (2016) J Autoimmun : 59-68
    › Primary publication · 27133598 (PubMed) · PMC4903931 (PubMed Central)